Ouabain, perillyl alcohol, and mTOR inhibitors (e.g., rapamycin, Torin1, and AZD8055) also interrupt the interactions of eIF4E and eIF4G in various cancer cells [201,202]. This evidence concerns the gene EIF4E and cancer.